How This Works
BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries. A Phase I oral safety trial has been completed, and a small human case series reported improvements following intra-articular administration; however, large-scale controlled human efficacy data are not yet available.
Potential Benefits & Side Effects
Observations from preclinical and early clinical literature.
Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data).
Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings.
Phase I safety studies report good tolerability with no serious adverse events at tested doses.
Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.
Long-term human safety and efficacy remain under investigation.
Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.